Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
A smart drug that stops cancer cells “hiding” from treatment can shrink tumours by at least...
Claude Lemieux’s brain is being donated to the Boston University CTE Center to research the long-term...
99% of chemicals in our food right now were added without FDA approval. Many were added...
